BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26228792)

  • 1. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.
    Dutta R; Dubal PM; Svider PF; Liu JK; Baredes S; Eloy JA
    Laryngoscope; 2015 Nov; 125(11):2491-7. PubMed ID: 26228792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of Patients with Sinonasal Cancers in a Population-Based Registry, Lombardy, Italy, 2008-2023.
    Consonni D; Stella S; Denaro N; Binazzi A; Dallari B; Rugarli S; Borello F; Coviello E; Mensi C
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinonasal Cancer Cases in a Nationwide Hospital Cancer Registry in Brazil, 2007-2021.
    Koller F; Consonni D; Mensi C; Nogueira LA; Ribeiro CO; Guimarães PRB; Kalinke LP
    Med Lav; 2024 Feb; 115(1):e2024004. PubMed ID: 38411978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the "Rome" Classification for Squamous Cell Carcinoma of the Nasal Vestibule.
    Scheurleer WFJ; de Ridder M; Tagliaferri L; Crescio C; Parrilla C; Mattiucci GC; Fionda B; Deganello A; Galli J; de Bree R; Rijken JA; Bussu F
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Life Prognosis of Sinonasal Tumors.
    Pecorari G; Motatto GM; Piazza F; Garzaro A; Riva G
    J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of sinonasal malignant tumors based on SEER database].
    Lyu HH; Lin JT; Wen YH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):392-398. PubMed ID: 38622025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
    Hermsen MA; Lechner M; Oliveira Ferrer L; Trama A; Eriksen PRG; Martinez-Balibrea E; von Buchwald C
    Oral Oncol; 2023 Nov; 146():106543. PubMed ID: 37573683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cerebral radiation necrosis following the treatment of sinonasal malignancies.
    Wu EL; Patel A; McGunigal MC; Johng SY; Mortazavi A; Jay AK; Ahn PH; Anaizi AN; DeKlotz TR
    Laryngoscope Investig Otolaryngol; 2024 Apr; 9(2):e1200. PubMed ID: 38525116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival characteristics of pediatric ganglioglioma from 2004 to 2018, with focus on infratentorial sites.
    Chen Y; Buchanan P; Brossier NM; Navalkele P
    Neurooncol Pract; 2024 Jun; 11(3):328-335. PubMed ID: 38737603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of social vulnerability impact in care and prognosis of sinonasal cancers in the United States.
    Kanaris AA; Fei-Zhang DJ; Fletcher LB; Smith SS; Patel UA; D'Souza JN; Chelius DC; Sheyn AM; Rastatter JC
    Int Forum Allergy Rhinol; 2024 Feb; ():. PubMed ID: 38343159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic pathway and stage migration of sinonasal malignancies in the era of the COVID-19 pandemic.
    Meerwein CM; Stadler TM; Balermpas P; Soyka MB; Holzmann D
    Laryngoscope Investig Otolaryngol; 2021 Oct; 6(5):904-910. PubMed ID: 34667832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to "Progress and emerging strategies to preserve function in the treatment of sinonasal cancer".
    Head Neck; 2024 Jan; 46(1):232. PubMed ID: 37983901
    [No Abstract]   [Full Text] [Related]  

  • 13. Squamous cell carcinoma of the nasal cavity: A population-based analysis.
    Unsal AA; Dubal PM; Patel TD; Vazquez A; Baredes S; Liu JK; Eloy JA
    Laryngoscope; 2016 Mar; 126(3):560-5. PubMed ID: 26297930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
    Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma.
    Cracchiolo JR; Patel K; Migliacci JC; Morris LT; Ganly I; Roman BR; McBride SM; Tabar VS; Cohen MA
    J Surg Oncol; 2018 Mar; 117(4):756-764. PubMed ID: 29193098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: Analysis from the national cancer database.
    Carey RM; Parasher AK; Workman AD; Yan CH; Glicksman JT; Chen J; Palmer JN; Adappa ND; Newman JG; Brant JA
    Laryngoscope; 2018 Mar; 128(3):560-567. PubMed ID: 28815617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal malignancies: incidence and histological distribution in Jamaica, 1973-2007.
    Gibson TN; McNaughton DP; Hanchard B
    Cancer Causes Control; 2017 Nov; 28(11):1219-1225. PubMed ID: 28646364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and survival outcomes of sinonasal verrucous carcinoma in the United States.
    Alonso JE; Han AY; Kuan EC; Suh JD; John MAS
    Laryngoscope; 2018 Mar; 128(3):651-656. PubMed ID: 28865078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.